June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Impact of High-Risk Features Associated with AMD Progression on Retinal Sensitivity
Author Affiliations & Notes
  • Houri Esmaeilkhanian
    Ophthalmology, Doheny Eye Institute, Los Angeles, California, United States
    Ophthalmology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Muneeswar Gupta Nittala
    Ophthalmology, Doheny Eye Institute, Los Angeles, California, United States
  • Swetha B Velaga
    Ophthalmology, Doheny Eye Institute, Los Angeles, California, United States
  • David G Birch
    Retina Foundation of the Southwest, Dallas, Texas, United States
  • Dwight Stambolian
    Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • SriniVas R Sadda
    Ophthalmology, Doheny Eye Institute, Los Angeles, California, United States
    Ophthalmology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Houri Esmaeilkhanian None; Muneeswar Gupta Nittala None; Swetha B Velaga None; David Birch None; Dwight Stambolian None; SriniVas Sadda 4DMT, Abbvie/Allergan, Amgen, Apellis, Astellas, Bayer, Biogen, Boerhinger Ingelheim, Centervue, Genentech/Roche, Heidelberg Engineering, Iveric, Nanoscope, Novartis, Optos, Oxurion, Regeneron, Code C (Consultant/Contractor), Carl Zeiss Meditec, Code F (Financial Support), Nidek, Code R (Recipient), Centervue, Heidelberg Engineering, Nidek, Optos, Topcon, Code S (non-remunerative)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 296. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Houri Esmaeilkhanian, Muneeswar Gupta Nittala, Swetha B Velaga, David G Birch, Dwight Stambolian, SriniVas R Sadda; Impact of High-Risk Features Associated with AMD Progression on Retinal Sensitivity. Invest. Ophthalmol. Vis. Sci. 2023;64(8):296.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A number of high-risk biomarkers for progression from intermediate age-related macular degeneration (AMD) to late AMD have been defined on optical coherence tomography (OCT). The objective of this study was to define the functional impact of these features using mesopic and scotopic microperimetry (MP).

Methods : Subjects with early/intermediate AMD enrolled in the Amish Eye Study who had mesopic, and scotopic MP, flash color fundus photography (CFP), and spectral-domain optical coherence tomography (SD-OCT) data were included in this post-hoc analysis. The presence and stage of AMD was assessed on CFPs in accordance with the Beckman scale. Scotopic and mesopic sensitivity were assessed using a Nidek MP-1S (pattern: macular grid, 32 stimuli, threshold strategy 4-2, fixation target 2° circle/cross, white background, stimulus size: Goldmann V). Foveal-centered SD-OCT volume scans [Spectralis OCT (20x20 degrees, 97 B-sans, ART=9) and Cirrus OCT (6x6 mm 512x128)] were reviewed for the presence or absence of previously-described features associated with a higher risk of progression to late AMD. These features include intraretinal hyperreflective foci (IHRF), hyporeflective drusen cores (hDC), high central drusen volume (CDV) ≥ 0.03mm3, subretinal drusenoid deposits (SDD). A Mann-Whitney U test was used to compare the mean sensitivity (MS), and a p-value ≤ 0.05 was considered statistically significant.

Results : 138 eyes of 69 patients (42 females) were included in this analysis. The mean age of patients was 66.63 ± 9.77 years. The scotopic and mesopic RS’s in eyes with or without the OCT biomarkers are shown in Table 1. Overall, the scotopic MS was lower than mesopic MS in this cohort for all evaluated biomarkers. The mesopic MS was significantly lower in AMD eyes with IHRF or SDD (p < 0.05). The scotopic MS was significantly lower in eyes with IHRF (p<0.05) and was numerically lower in eyes with SDD, though this was not statistically significant. The presence of hCD or high CDV did not seem to be associated with an impact on MS.

Conclusions : The presence of IHRF is associated with both a lower mesopic and scotopic MS, while the presence of SDD is associated with lower mesopic RS. Larger studies may be required to better define the functional impact of these and other AMD biomarkers.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Table 1. shows the mean sensitivity in the presence and absence of high-risk features for AMD progression.

Table 1. shows the mean sensitivity in the presence and absence of high-risk features for AMD progression.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×